Abstract
In the Advance Notice of Proposed Rulemaking issued in March 2018, the US Food and Drug Administration expressed interest in developing a tobacco product standard that would limit nicotine levels in cigarettes to make them minimally addictive.1 This commentary highlights evidence relevant to the nicotine level that would most benefit public health, the scope of products to which maximum nicotine level product standard should apply, and whether other constituent standards are necessary to meaningfully minimize addictiveness.
Original language | English (US) |
---|---|
Pages (from-to) | S13-S15 |
Journal | Nicotine and Tobacco Research |
Volume | 21 |
DOIs | |
State | Published - Dec 23 2019 |
Externally published | Yes |
ASJC Scopus subject areas
- Public Health, Environmental and Occupational Health